- Home
- CNXN vs OCS Comparison
CNXN vs OCS Comparison
Compare CNXN & OCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CNXN | OCS |
|---|---|---|
| Founded | 1982 | 2003 |
| Country | United States | Switzerland |
| Employees | N/A | 60 |
| Industry | Catalog/Specialty Distribution | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.8B |
| IPO Year | 1997 | N/A |
Fundamental Metrics
Financial Performance| Metric | CNXN | OCS |
|---|---|---|
| Price | $70.14 | $11.95 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $42.00 |
| AVG Volume (30 Days) | 139.6K | ★ 1.2M |
| Earning Date | 04-29-2026 | 05-07-2026 |
| Dividend Yield | ★ 1.26% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.68 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $6.24 | $466.06 |
| Revenue Next Year | $4.39 | $479.73 |
| P/E Ratio | $104.57 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $54.97 | $10.52 |
| 52 Week High | $75.00 | $34.48 |
Technical Indicators
Market Signals| Indicator | CNXN | OCS |
|---|---|---|
| Relative Strength Index (RSI) | 53.59 | 29.24 |
| Support Level | $56.30 | $10.52 |
| Resistance Level | $75.00 | $21.82 |
| Average True Range (ATR) | 2.14 | 0.66 |
| MACD | -0.40 | 0.55 |
| Stochastic Oscillator | 30.49 | 84.85 |
Price Performance
Historical ComparisonAbout CNXN PC Connection Inc.
PC Connection Inc is a provider of information technology solutions. It provides products such as computer systems, software and peripheral equipment, networking communications, and other products and accessories that company purchase from manufacturers and distributors. The company also offers services involving design, configuration, and implementation of IT solutions. It conducts business operations through three business segments namely Connection Business Solutions, Connection Enterprise Solutions, and Connection Public Sector Solutions. The company generates maximum revenue Connection Enterprise Solutions segment.
About OCS Oculis Holding AG Ordinary shares
Oculis Holding AG is a biopharmaceutical company purposefully driven to save sight and improve eye care. It includes OCS-01, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED); and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis. The Company has locations in five countries: Switzerland, Iceland, France, U.S. and Hong Kong.